1.
Interleukin-6: A Masterplayer in the Cytokine Network
by Uciechowski, Peter
Oncology, 2020-02, Vol.98 (3), p.131-137
2.
Gene of the month: Interleukin 6 (IL-6)
by Ataie-Kachoie, Parvin
Journal of clinical pathology, 2014-11, Vol.67 (11), p.932-937
3.
Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
by Wang, Yue
Cancer letters, 2010, Vol.295 (1), p.110-123
4.
IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3
by Desai, Avanti, MSc
Journal of allergy and clinical immunology, 2015, Vol.137 (6), p.1863-1871.e6
5.
The cell-cell interaction between tumor-associated macrophages and small cell lung cancer cells is involved in tumor progression via STAT3 activation
by Iriki, Toyohisa
Lung cancer (Amsterdam, Netherlands), 2017, Vol.106, p.22-32
6.
The IL6R variation Asp(358)Ala is a potential modifier of lung function in subjects with asthma
by Hawkins, Gregory A
Journal of allergy and clinical immunology, 2012-08, Vol.130 (2), p.510-5.e1
7.
Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps
by Peters, Anju T., MD
Journal of allergy and clinical immunology, 2010, Vol.125 (2), p.397-403.e10
8.
The Role of IL-6 Trans-Signaling in Vascular Leakage: Implications for Ovarian Hyperstimulation Syndrome in a Murine Model
by Wei, Lin-Hung
The journal of clinical endocrinology and metabolism, 2013-03, Vol.98 (3), p.E472-E484
9.
Interleukin-10 attenuates tumour growth by inhibiting interleukin-6/signal transducer and activator of transcription 3 signalling in myeloid-derived suppressor cells
by Lee, Bo-Ra
Cancer letters, 2016, Vol.381 (1), p.156-164
10.
One week of magnesium supplementation lowers IL-6, muscle soreness and increases post-exercise blood glucose in response to downhill running
by Steward, Charles James
European journal of applied physiology, 2019-10-17, Vol.119 (11-12), p.2617-2627
11.
IL-23/IL-17A Axis Correlates with the Nitric Oxide Pathway in Inflammatory Bowel Disease: Immunomodulatory Effect of Retinoic Acid
by Rafa, Hayet
Journal of interferon & cytokine research, 2013-07-01, Vol.33 (7), p.355-368
12.
IL-6 promotes ICAM-1 expression and cell motility in human osteosarcoma
by Lin, Yu-Min
Cancer letters, 2012, Vol.328 (1), p.135-143
13.
Comparison of the inflammatory response of brain microvascular and peripheral endothelial cells following infection with Neisseria meningitidis
by Dick, Julia
Pathogens and disease, 2017-07-31, Vol.75 (5)
14.
Mitigating Cellular Inflammation in Older Adults: A Randomized Controlled Trial of Tai Chi Chih
by Irwin, Michael R., M.D
The American journal of geriatric psychiatry, 2012, Vol.20 (9), p.764-772
15.
IL-6 transsignaling: the in vivo consequences
by Jones, Simon A
Journal of interferon & cytokine research, 2005-05, Vol.25 (5), p.241-253
16.
Expression of the Interleukin 6 System in Cortical Lesions From Patients With Tuberous Sclerosis Complex and Focal Cortical Dysplasia Type IIb
by Shu, Hai-Feng
Journal of neuropathology and experimental neurology, 2010-08, Vol.69 (8), p.838-849
17.
IL-6 Up-Regulates the Expression of Rat LH Receptors during Granulosa Cell Differentiation
by Imai, Fumiharu
Endocrinology (Philadelphia), 2014-04, Vol.155 (4), p.1436-1444
18.
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
by Ellingsgaard, Helga
Nature medicine, 2011-10-30, Vol.17 (11), p.1481-1489
19.
Therapeutic targeting of interleukin-6 trans-signaling does not affect the outcome of experimental tuberculosis
by Sodenkamp, Jan
Immunobiology (1979), 2012, Vol.217 (10), p.996-1004
20.
Establishment of a novel cell-based assay for screening small molecule antagonists of human interleukin-6 receptor
by He, Yang-yang
Acta pharmacologica Sinica, 2014, Vol.35 (11), p.1453-1462
